![\"In](\"https:\/\/www.europesays.com\/ie\/wp-content\/uploads\/2025\/11\/1763043677_894_0x0.jpg\")
<\/p>\n<\/p>\n
CANADA – 2025\/10\/01: In this photo illustration, the UnitedHealth Group (United Health) logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller\/SOPA Images\/LightRocket via Getty Images)<\/p>\n
SOPA Images\/LightRocket via Getty Images<\/p>\n
UnitedHealth Group stock<\/a> (NYSE: UNH) has declined by 7% over the past month. This downturn is attributed to several significant investor concerns, including rising medical costs within its Medicare Advantage plans, ongoing regulatory and legal scrutiny, and margin pressures in the Optum division. These challenges have overshadowed the positive news delivered in the company’s third-quarter earnings report. Given this recent fall, it is an opportune time to evaluate how UNH stock is currently performing relative to its peers.<\/p>\n This is how UnitedHealth stock compares to its competitors in terms of size, valuation, growth, and margins.<\/p>\n For some background, UnitedHealth<\/a> offers a variety of health care services, including consumer health benefit plans for different employers and individuals, as well as pharmacy care services such as retail, home delivery, specialty, and clinical programs.<\/p>\n Investing in a single stock can be risky; however, a broad, diversified strategy can offer significant value. If you\u2019re looking for potential growth with reduced volatility compared to holding an individual stock, consider the Trefis High Quality Portfolio<\/a> (HQ). The HQ has outperformed its benchmark – a mix of the S&P 500, Russell, and S&P midcap indices – achieving returns that have exceeded 105% since it was established. Effective risk management is crucial – think about the potential long-term performance of a blend consisting of 10% commodities, 10% gold, and 2% cryptocurrency alongside HQ\u2019s performance metrics<\/a>.<\/p>\n UNH Stock vs. Peers<\/p>\n Trefis<\/p>\n Why does this matter?<\/strong> UNH recently fell by 8.7% in a month – comparing it to peers puts stock performance, valuation, and financials into perspective – indicating whether it is genuinely outperforming, underperforming, and crucially, can this trend persist? Read Buy or Sell UNH Stock<\/a> to determine if UnitedHealth is indeed a falling knife. Sharp declines often present rebound opportunities – observe how the stock has dipped and recovered historically through the UNH Dip Buyer Analysis<\/a> perspective.<\/p>\n Revenue Growth Comparison<\/p>\n UNH Revenue Growth Comparison<\/p>\n TrefisOperating Margin Comparison<\/p>\n UNH Operating Margin Comparison<\/p>\n TrefisPE Ratio Comparison<\/p>\n UNH Stock PE Ratio Comparison<\/p>\n Trefis<\/p>\n While comparing peers is vital, the Trefis High Quality (HQ) Portfolio<\/a>, featuring a selection of 30 stocks, has a history of consistently outperforming its benchmark<\/strong>, which comprises all three – the S&P 500, S&P Mid-cap, and Russell 2000 indices. What accounts for this?<\/strong> Collectively, HQ Portfolio stocks have delivered superior returns with reduced risk compared to the benchmark index; creating a less volatile experience, as demonstrated in HQ Portfolio performance metrics<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"CANADA – 2025\/10\/01: In this photo illustration, the UnitedHealth Group (United Health) logo is seen displayed on a…\n","protected":false},"author":2,"featured_media":178589,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[275],"tags":[18,135,475,474,19,17,101133,101131,101134,101132,616,67129,101130],"class_list":{"0":"post-178588","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-eire","9":"tag-health","10":"tag-health-care","11":"tag-healthcare","12":"tag-ie","13":"tag-ireland","14":"tag-unh","15":"tag-unh-revenues","16":"tag-unh-stock-analysis","17":"tag-unh-valuation","18":"tag-unitedhealth","19":"tag-unitedhealth-group","20":"tag-unitedhealth-stock"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/115542837683324163","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/178588","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=178588"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/178588\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/178589"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=178588"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=178588"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=178588"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n